IRONWOOD PHARMACEUTICALS INC·4

Jan 19, 4:05 PM ET

Rickard Jason 4

4 · IRONWOOD PHARMACEUTICALS INC · Filed Jan 19, 2023

Insider Transaction Report

Form 4
Period: 2023-01-17
Rickard Jason
SVP, Chief Operating Officer
Transactions
  • Award

    Class A Common Stock

    2023-01-17+18,087366,823 total
Footnotes (1)
  • [F1]Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted February 27, 2020. The earned PSUs were certified and vested on January 17, 2023.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION